Cleared Traditional

K800925 - VERIFY S PROD. #34141

K800925 is an FDA 510(k) clearance for VERIFY S PROD. #34141, manufactured by General Diagnostics. The device is a Class 2 Hematology device with product code GGW cleared through the Traditional 510(k) pathway after a 91-day FDA review.

K800925 · General Diagnostics · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1980
Decision
91d
Days
Class 2
Risk

K800925 is an FDA 510(k) clearance for the VERIFY S PROD. #34141. Classified as Test, Time, Partial Thromboplastin (product code GGW), Class II - Special Controls.

Submitted by General Diagnostics (Mchenry, US). The FDA issued a Cleared decision on July 21, 1980 after a review of 91 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7925 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all General Diagnostics devices

FDA 510(k) Submission Details - K800925

510(k) Number K800925 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 21, 1980
Decision Date July 21, 1980
Days to Decision 91 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d faster than avg
Panel avg: 113d · This submission: 91d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GGW Device Classification - Class 2, Special Controls

Product Code GGW Test, Time, Partial Thromboplastin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7925
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GGW Test, Time, Partial Thromboplastin

All 27
Devices cleared under the same product code (GGW) and FDA review panel - the closest regulatory comparables to K800925.
AB-TROL COAGULATION CONTROL
K802232 · Helena Laboratories · Nov 1980
HEP-TROL
K801932 · Helena Laboratories · Sep 1980
PACIFIC HEMOSTASIS THROMBO-SCREEN KAPTT
K801460 · Pacific Hemostasis · Jul 1980
ANTIBODY TO VARICELLA-ZOSTER VIRUS
K800787 · Electro-Nucleonics Laboratories, Inc. · Jul 1980
A-GENT QUANTICHROM THROMBIGEN I
K800725 · Abbott Laboratories · Jun 1980
LANCER COAGENT APTT KIT
K792048 · Sherwood Medical Co. · Nov 1979